By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Introgen Therapeutics, Inc. 

301 Congress Avenue, Suite 1850

Austin  Texas  78701  U.S.A.
Phone: 512-320-5010 Fax: 512-320-4166


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
Introgen Therapeutics, Inc. (INGN) Announces Resignation of David G. Nance from Board of Directors 3/12/2009 9:21:26 AM
Introgen Therapeutics, Inc. (INGN) Common Stock to be Delisted from the Nasdaq Stock Market 12/8/2008 10:58:17 AM
Introgen Therapeutics, Inc. (INGN) Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities; Reduces Staff 12/1/2008 7:12:04 AM
Introgen Therapeutics, Inc. (INGN) Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market 11/19/2008 9:07:56 AM
Introgen Therapeutics, Inc. (INGN) Hires An Adviser To Pursue Strategic Options, Including A Possible Sale 11/12/2008 7:10:59 AM
Introgen Therapeutics, Inc. (INGN) Reports Third Quarter 2008 Financial Results 11/11/2008 9:45:39 AM
Introgen Therapeutics, Inc. (INGN) Receives Notification From NASDAQ 10/6/2008 10:49:46 AM
Introgen Therapeutics, Inc. (INGN) Receives Staff Determination Letter from Nasdaq Global Market 9/8/2008 9:13:06 AM
Introgen Therapeutics, Inc. (INGN) Sell-Off Continues 9/4/2008 11:25:03 AM
Introgen Therapeutics, Inc. (INGN) Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File 9/2/2008 6:37:25 AM
12345678910...
//-->